Danofloxacin mesylate

CAS No. 119478-55-6

Danofloxacin mesylate( CP 76,136-27 )

Catalog No. M10686 CAS No. 119478-55-6

Danofloxacin is a synthetic antibacterial agent of the fluoroquinolone class, acts principally by the inhibition of bacterial DNA-gyrase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 42 In Stock
5MG 61 In Stock
10MG 101 In Stock
25MG 181 In Stock
50MG 314 In Stock
100MG 467 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Danofloxacin mesylate
  • Note
    Research use only, not for human use.
  • Brief Description
    Danofloxacin is a synthetic antibacterial agent of the fluoroquinolone class, acts principally by the inhibition of bacterial DNA-gyrase.
  • Description
    Danofloxacin is a synthetic antibacterial agent of the fluoroquinolone class, acts principally by the inhibition of bacterial DNA-gyrase, which is necessary for supercoiling of DNA to provide a suitable spatial arrangement of DNA within the bacterial cell.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CP 76,136-27
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    DNA-gyrase
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    119478-55-6
  • Formula Weight
    453.48
  • Molecular Formula
    C19H20FN3O3·CH4O3S
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 91 mg/mL (200.67 mM)
  • SMILES
    CN1C[C@@H]2C[C@H]1CN2C3=C(C=C4C(=C3)N(C=C(C4=O)C(=O)O)C5CC5)F.CS(=O)(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Giles CJ, et al. J Vet Pharmacol Ther, 1991, 14(4), 400-410.
molnova catalog
related products
  • VAL-083

    VAL-083 is an alkylating compound that creates N7 methylation on DNA. It also has antitumor activity.

  • Clevudine

    Clevudine is an antiviral drug for the treatment of hepatitis B.

  • T863

    T-863(DGAT-1 inhibitor) is an orally active, selective and potent DGAT1 (Acyl-CoA:diacylglycerol acyltransferase 1) inhibitor that interacts with the acyl-CoA binding site of DGAT1, and inhibits triacylglycerol synthesis in cells.